Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A2 | P43004 | 3/20 | 0.38 |
| ▸ | SLC1A1 | P43005 | 3/20 | 0.38 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.38 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.38 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.38 |
| ▸ | DDAH1 | O94760 | 4/20 | 0.35 |
| ▸ | NOS1 | P29475 | 3/20 | 0.35 |
| ▸ | DPP4 | P27487 | 2/20 | 0.35 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.35 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.35 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | HTR2C | P28335 | 1/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.33 |
| ▸ | HRH1 | P35367 | 1/20 | 0.33 |
| ▸ | DRD3 | P35462 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2514287 | 0.79 | ALOX15 (0.54) | SLC1A2SLC1A1SLC1A3GRIK1GRIK2 | |
| SCHEMBL29588125 | 0.79 | ANPEP (0.36) | ALOX15 | |
| SCHEMBL28077575 | 0.79 | RNPEP (0.37) | NOS1METAP1NOS3NOS2 | |
| SCHEMBL2516159 | 0.78 | GSR (0.45) | DDAH1NOS1DPP4DPP7DPP8 | |
| SCHEMBL28181158 | 0.77 | GRIK1 (0.34) | SLC1A2SLC1A1SLC1A3GRIK1GRIK2 | |
| SCHEMBL13409447 | 0.76 | ARG2 (0.31) | — | |
| SCHEMBL2890597 | 0.76 | — | — | |
| SCHEMBL3195552 | 0.76 | ALOX15 (0.44) | SLC1A2SLC1A1SLC1A3GRIK1GRIK2 | |
| SCHEMBL628809 | 0.76 | — | — | |
| SCHEMBL3195561 | 0.76 | ALOX15 (0.44) | SLC1A2SLC1A1SLC1A3GRIK1GRIK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260115150-A1 | FORMULATIONS COMPRISING INOSITOL, SILICATES, AND OPTIONALLY AMINO ACIDS WITH IMPROVED SOLUBILITY AND METHODS OF MAKING THE SAME | NUTRITION21 LLC (US) | 2026-04-30 | — | — | US | disclosed |
| US-11260039-B1 | Amino acid compositions | THERMOLIFE INTERNATIONAL, LLC (US) | 2022-03-01 | — | — | US | disclosed |
| US-11155524-B2 | Amino acid compositions | THERMOLIFE INTERNATIONAL, LLC (US) | 2021-10-26 | — | — | US | disclosed |
| US-10894025-B1 | Amino acid compositions | THERMOLIFE INTERNATIONAL, LLC (US) | 2021-01-19 | — | — | US | disclosed |
| US-20200297678-A1 | Amino Acid Compositions | THERMOLIFE INTERNATIONAL, LLC | 2020-09-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11260039-B1 | Amino acid compositions | ARG1, ARG2, GLS | SLC1A2 41/4885SLC1A1 47/4885SLC1A3 42/4885 |
| US-10894025-B1 | Amino acid compositions | ARG1, PYGM, NOS1 | SLC1A2 279/4885SLC1A1 294/4885SLC1A3 248/4885 |
| US-20200297678-A1 | Amino Acid Compositions | ASNS, ARGLU1, SLC6A15 | SLC1A2 36/4885SLC1A1 37/4885SLC1A3 45/4885 |
| US-20260115150-A1 | FORMULATIONS COMPRISING INOSITOL, SILICATES, AND OPTIONALLY AMINO ACIDS WITH IMPROVED SOLUBILITY AND METHODS OF MAKING THE SAME | CUTA, NOS1, NOS2 | SLC1A2 104/4885SLC1A1 94/4885SLC1A3 60/4885 |
| US-11155524-B2 | Amino acid compositions | ASNS, ARGLU1, SLC6A15 | SLC1A2 36/4885SLC1A1 37/4885SLC1A3 45/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.